Prediction of gram-negative bacteremia in patients with cancer and febrile neutropenia by means of interleukin-8 levels in serum: Targeting empirical monotherapy versus combination therapy

Clinical Infectious Diseases

Volumn 32, Issue 5, 2001, Pages 832-835

  Kern, Winfried V ^a   Heiss, Monika ^a   Steinbach, Gerald ^a  

^a UNIVERSITY HOSPITAL ULM   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CARBAPENEM; CEFEPIME; CEFTAZIDIME; INTERLEUKIN 8;

ADULT; AGED; ARTICLE; BACTEREMIA; BLOOD CULTURE; BLOOD SAMPLING; CANCER PATIENT; EARLY DIAGNOSIS; FEMALE; GRAM NEGATIVE SEPSIS; HIGH RISK POPULATION; HUMAN; INFECTION RISK; MAJOR CLINICAL STUDY; MALE; NEUTROPENIA; PREDICTION; PRIORITY JOURNAL; RISK BENEFIT ANALYSIS;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BACTEREMIA; CEPHALOSPORINS; DRUG THERAPY, COMBINATION; FEVER; GENTAMICINS; GRAM-NEGATIVE BACTERIAL INFECTIONS; HUMANS; INTERLEUKIN-8; LEUKEMIA; LYMPHOMA; MALE; MIDDLE AGED; NETILMICIN; NEUTROPENIA; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES;

EID: 0035282531     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/319207     Document Type: Article

References (13)

1. 1997 Guidelines for the use of antimicrobial agents in neutropenic patients with unexplained fever
2. Ceftazidime combined with a short or long course of amikacin for empirical therapy of gram-negative bacteremia in cancer patients with granulocytopenia
3. A comparison of imipenem to ceftazidime with or without amikacin as empiric therapy in febrile neutropenic patients
4. Monotherapy versus β-lactamaminoglycoside combination treatment for gram-negative bacteremia: A prospective, observational study
5. An analysis of interleukin-6, interleukin-8 and C-reactive protein serum concentrations to predict fever, gram-negative bacteremia and complicated infection in neutropenic cancer patients
6. Diagnostic value of procalcitonin serum levels in neutropenic patients with fever: Comparison with interleukin-8
7. Assessment of measuring circulating levels of interleukin-6, interleukin-8, C-reactive protein, soluble Fcδ receptor type III, and mannose-binding protein in febrile children with cancer and neutropenia
8. The APACHE III prognostic system: Risk prediction of hospital mortality for critically ill hospitalized adults
9. Vancomycin added to empirical combination therapy for fever in granulocytopenic cancer patients
10. Early identification of neutropenic patients at risk of gram-positive bacteraemia and the impact of empirical administration of vancomycin
11. Open randomized study of cefepime versus piperacillin-gentamicin for treatment of febrile neutropenic cancer patients
12. Cefepime versus imipenemcilastatin as empirical monotherapy in 400 febrile patients with short duration neutropenia
13. Piperacillin/tazobactam versus cefepime as initial empirical antimicrobial therapy in febrile neutropenic patients: A prospective randomized pilot study